Literature DB >> 25203417

Lack of harmonization in sweat testing for cystic fibrosis - a national survey.

Anne Lindegaard Christiansen1, Mads Nybo.   

Abstract

INTRODUCTION: Sweat testing is used in the diagnosis of cystic fibrosis. Interpretation of the sweat test depends, however, on the method performed since conductivity, osmolality and chloride concentration all can be measured as part of a sweat test. The aim of this study was to investigate how performance of the test is organized in Denmark.
METHODS: Departments conducting the sweat test were contacted and interviewed following a premade questionnaire. They were asked about methods performed, applied NPU (Nomenclature for Properties and Units) code, reference interval, recommended interpretation and referred literature.
RESULTS: 14 departments performed the sweat test. One department measured chloride and sodium concentration, while 13 departments measured conductivity. One department used a non-existing NPU code, two departments applied NPU codes inconsistent with the method performed, four departments applied no NPU code and seven applied a correct NPU code. Ten of the departments measuring conductivity applied reference intervals. Nine departments measuring conductivity had recommendations of a normal area, a grey zone and a pathological value, while four departments only applied a normal and grey zone or a pathological value. Cut-off values for normal, grey and pathological areas were like the reference intervals inconsistent.
CONCLUSION: There is inconsistent use of NPU codes, reference intervals and interpretation of sweat conductivity used in the process of diagnosing cystic fibrosis. Because diagnosing cystic fibrosis is a combined effort between local pediatric departments, biochemical and genetic departments and cystic fibrosis centers, a national harmonization is necessary to assure correct clinical use.

Entities:  

Keywords:  Chlorides; cystic fibrosis; diagnosis; screening and sweat

Mesh:

Substances:

Year:  2014        PMID: 25203417     DOI: 10.3109/00365513.2014.953992

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  6 in total

1.  Elevated sweat chloride test: is it always cystic fibrosis?

Authors:  C Cimbalo; A Tosco; V Terlizzi; A Sepe; A Castaldo; L Salvadori; V Raia
Journal:  Ital J Pediatr       Date:  2021-05-14       Impact factor: 2.638

2.  S737F is a new CFTR mutation typical of patients originally from the Tuscany region in Italy.

Authors:  Vito Terlizzi; Antonella Miriam Di Lullo; Marika Comegna; Claudia Centrone; Elisabetta Pelo; Giuseppe Castaldo; Valeria Raia; Cesare Braggion
Journal:  Ital J Pediatr       Date:  2018-01-03       Impact factor: 2.638

3.  Evaluating performance in sweat testing in medical biochemistry laboratories in Croatia.

Authors:  Merica Aralica; Jasna Lenicek Krleza
Journal:  Biochem Med (Zagreb)       Date:  2017-02-15       Impact factor: 2.313

4.  Quality of sweat test (ST) based on the proportion of sweat sodium (Na) and sweat chloride (Cl) as diagnostic parameter of cystic fibrosis: are we on the right way?

Authors:  Alethéa Guimarães Faria; Fernando Augusto Lima Marson; Carla Cristina de Souza Gomez; Maria Ângela Gonçalves de Oliveira Ribeiro; Lucas Brioschi Morais; Maria de Fátima Servidoni; Carmen Sílvia Bertuzzo; Eulália Sakano; Maura Goto; Ilma Aparecida Paschoal; Mônica Corso Pereira; Gabriel Hessel; Carlos Emílio Levy; Adyléia Aparecida Dalbo Contrera Toro; Andressa Oliveira Peixoto; Maria Cristina Ribeiro Simões; Elizete Aparecida Lomazi; Roberto José Negrão Nogueira; Antônio Fernando Ribeiro; José Dirceu Ribeiro
Journal:  Diagn Pathol       Date:  2016-10-26       Impact factor: 2.644

5.  Standardized clinical criteria and sweat test combined as a tool to diagnose Cystic Fibrosis.

Authors:  Fabricio González-Andrade
Journal:  Heliyon       Date:  2018-12-17

6.  Impact of Pancreatitis-Associated Protein on Newborn Screening Outcomes and Detection of CFTR-Related Metabolic Syndrome (CRMS)/Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A Monocentric Prospective Pilot Experience.

Authors:  Chiara Bianchimani; Daniela Dolce; Claudia Centrone; Silvia Campana; Novella Ravenni; Tommaso Orioli; Erica Camera; Gianfranco Mergni; Cristina Fevola; Paolo Bonomi; Giovanni Taccetti; Vito Terlizzi
Journal:  Int J Neonatal Screen       Date:  2022-08-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.